HTL Biotechnology launches HTL8, a production unit dedicated to pharmaceutical-grade polynucleotides (DNA)
JAVENÉ, France, Nov. 13, 2026 /PRNewswire/ -- Thursday, November 12, HTL Biotechnology, a world leader in the development and production of pharmaceutical-grade biopolymers, inaugurated its new production unit, HTL8, dedicated to the manufacture of pharmaceutical-grade polynucleotides, at...
Covered in this story
Call it yourself
No calls on $DNA yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Ginkgo Bioworks Holdings Inc Class →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.